All That Jazz at the F.D.A.
Wednesday, August 25, 2010 - 14:49
in Mathematics & Economics
The story behind the 20-2 FDA advisory panel vote against Jazz Pharmaceuticals.
The story behind the 20-2 FDA advisory panel vote against Jazz Pharmaceuticals.